NCT05749679Not yet recruiting
Prevention of Renal Failure in People Followed for Type 2 Diabetes in General Practice
Prevention of NEphronic PErt in People With Type 2 DIABETIC Disease Followed in General Practice
Source: ClinicalTrials.gov · Last updated 26 Dec 2025
Brief summary (registry, in English)
This work will make it possible to identify the nephron loss of type 2 diabetic patients in the western region and to better define in general practice the impact of the elements put in place to reduce this loss and to raise awareness of the importance of these measures through training in comparison with a control group.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 360 (estimated)
- First submitted
- 17 Feb 2023
- Start date
- Jul 2026
- Primary completion date
- May 2027
- Lead sponsor
- University Hospital, Lille
- Diseases
- Type 2 diabetes
- NCT number
- NCT05749679
What you commit to
- Study type: Interventional
- Planned participants: 360
- From Jul 2026 to the primary completion date, May 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Patient under 50 years of age Patients who do not agree to the use of their data (refusal of consent) or are unable to give consent (dementia, other) Patients with other types of diabetes Patients with renal failure other than diabetic or hypertensive glomerulopathy Patients unable to give consent Patients who do not understand the French language Patients with less than 3 months of planned follow-up Patients with a barrier to follow-up Patients undergoing dialysis, transplantation
Who the study is looking for
- Patient consulting his or her investigating general practitioner
- 50 years old or more
- type 2 diabetic for more than 5 years, with a GFR lower than 90 ml/mn and higher than 45 ml/mn (stage 2 and 3a of renal failure) and a nephron loss calculated on the average of the two previous years, higher than 3 ml/mn/year
- a microalbuminuria \> 30 mg/gr of creatinuria.
- Having declared the investigator as the treating physician
Age in the registry: 50 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.